Intervention Review

Polyunsaturated fatty acid supplementation for schizophrenia

  1. Claire B Irving1,*,
  2. Roger Mumby-Croft2,
  3. L A Joy3

Editorial Group: Cochrane Schizophrenia Group

Published Online: 20 JAN 2010

Assessed as up-to-date: 11 FEB 2009

DOI: 10.1002/14651858.CD001257.pub2

Database Title

Additional Information

How to Cite

Irving CB, Mumby-Croft R, Joy LA. Polyunsaturated fatty acid supplementation for schizophrenia. Cochrane Database of Systematic Reviews 2006, Issue 3. Art. No.: CD001257. DOI: 10.1002/14651858.CD001257.pub2.

Author Information

  1. 1

    The University of Nottingham, Cochrane Schizophrenia Group, Nottingham, UK

  2. 2

    Westminster College, Oxford, UK

  3. 3

    Frampton Mansell, Gloucestershire, UK

*Claire B Irving, Cochrane Schizophrenia Group, The University of Nottingham, Institute of Mental Health, Sir Colin Campbell Building, University of Nottingham Innovation Park, Triumph Road, Nottingham, NG7 2TU, UK. Claire.Irving@nottingham.ac.uk. claireirving@btinternet.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 20 JAN 2010

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (61K)Standard (411K)Full (676K)

  1. Current Version

    Polyunsaturated fatty acid supplementation for schizophrenia

    Claire B Irving, Roger Mumby-Croft and L A Joy

    Article first published online: 20 JAN 2010 | DOI: 10.1002/14651858.CD001257.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Polyunsaturated fatty acid supplementation for schizophrenia

    CB Joy, R Mumby-Croft and LA Joy

    Article first published online: 19 APR 2006 | DOI: 10.1002/14651858.CD001257

View Full Article (HTML) Summary (61K)Standard (411K)Full (676K)